REEV, a medtech startup from Toulouse, France, has successfully raised $9.2 million in funding led by Newfund Heka and other notable investors. The funds will facilitate the final design of their motorized orthosis, DREEVEN, enable clinical studies at Boston University, and prepare for U.S. FDA trials. Co-founders Amaury Ciurana and Dr. Robin Temporelli aim to improve mobility for neurological patients while reshaping the orthotics industry. Support also comes from influencers like French soccer player Raphael Varane, highlighting the project's broad appeal and the potential for transformative impact.
We are proud to continue supporting REEV as they work toward FDA clearance to bring their technology to market in the U.S. This marks a key milestone in improving mobility for neurological patients.
With the support of our world-class partners, we are thrilled to enter the next phase of clinical and industrial development. Our innovative technologies, like the DREEVEN motorised orthosis, aim to redefine mobility assistance, transforming lives and reshaping the orthotics industry.
Collection
[
|
...
]